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AGAP1 is an Arf1 GTPase activating protein that interacts with the vesicle-associated
protein complexes adaptor protein 3 (AP-3) and Biogenesis of Lysosome Related
Organelles Complex-1 (BLOC-1). Overexpression of AGAP1 in non-neuronal cells
results in an accumulation of endosomal cargoes, which suggests a role in endosome-
dependent traffic. In addition, AGAP1 is a candidate susceptibility gene for two
neurodevelopmental disorders, autism spectrum disorder (ASD) and schizophrenia (SZ);
yet its localization and function in neurons have not been described. Here, we
describe that AGAP1 localizes to axons, dendrites, dendritic spines and synapses,
colocalizing preferentially with markers of early and recycling endosomes. Functional
studies reveal overexpression and down-regulation of AGAP1 affects both neuronal
endosomal trafficking and dendritic spine morphology, supporting a role for AGAP1
in the recycling endosomal trafficking involved in their morphogenesis. Finally, we
determined the sensitivity of AGAP1 expression to mutations in the DTNBP1 gene,
which is associated with neurodevelopmental disorder, and found that AGAP1 mRNA
and protein levels are selectively reduced in the null allele of the mouse ortholog of
DTNBP1. We postulate that endosomal trafficking contributes to the pathogenesis of
neurodevelopmental disorders affecting dendritic spine morphology, and thus excitatory
synapse structure and function.
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INTRODUCTION
ADP-ribosylation factors (Arfs) are members of the Ras superfamily of GTPases that
participate in membrane trafficking along the secretory and endosomal pathways (Powelka
and Buckley, 2001; Bader et al., 2004; Randazzo and Hirsch, 2004; D’Souza-Schorey and
Chavrier, 2006; Nie and Randazzo, 2006; Wang et al., 2006). Arf GTP binding is catalyzed
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by GTPase activating proteins (GAPs; Donaldson and Jackson,
2000; Nie and Randazzo, 2006). Arf1 GTPase activating protein
(AGAP1) is a member of the AZAP family of phosphoinositide-
regulated Arf GAPs, whose members contain a conserved Arf
GAP domain, pleckstrin homology (PH) domain and ankyrin
repeats (Nie et al., 2002). AZAPs regulate membrane traffic by
specifying the time and place of coat recruitment to generate
nascent vesicles and possibly as part of the coat during vesicle
budding (Randazzo and Hirsch, 2004).
In this study, we focus on AGAP1 (also called GGAP,
KIAA1099 and centaurin γ-2/CENTG2), which has been
primarily described in non-neuronal cells, where AGAP1
up-regulation results in impaired endosomal trafficking
(Nie et al., 2002). AGAP1 associates with the endosomal
complexes adaptor protein 3 (AP-3) and Biogenesis of
Lysosome Related Organelles Complex-1 (BLOC-1: Nie
et al., 2005; Bendor et al., 2010). In neuronal cells, AGAP1
is necessary for the recycling of muscarinic acetylcholine
receptors in association with the AP-3 adaptor and with
dysbindin, a subunit of the BLOC-1 (Bendor et al., 2010).
Diverse evidence suggests that AGAP1, AP-3, and BLOC-1
subunits are risk factors in neurodevelopmental disorders.
The BLOC-1 subunit dysbindin encoded by the gene DTNBP1
is a risk factor for schizophrenia (SZ) and autism spectrum
disorder (ASD; Tang et al., 2009; Greenwood et al., 2011;
Di Benedetto et al., 2013); indeed, the dysbindin levels are
lower in the brains of individuals with SZ (Talbot et al.,
2004). The neuronal specific AP-3 subunit AP-3 beta2 is also
a risk factor for ASD (O’Roak et al., 2012). Furthermore,
AGAP1 is a candidate ASD susceptibility gene (Wassink
et al., 2005; Sebat et al., 2007), and has been reported as a
potential risk factor in a genome-wide association studies
(GWAS) of SZ (Shi et al., 2009). These data support the
hypothesis that impaired mechanisms of AGAP1-dependent
endosomal trafficking contribute to the pathogenesis of
neurodevelopmental disorders such as ASD and SZ (Ryder
and Faundez, 2009). However, AGAP1 localization, function,
and susceptibility to mutations in genes associated with
neurodevelopmental disorders have not been explored in
neurons.
We examined the expression levels and subcellular
localization of endogenous AGAP1 in primary neurons,
and investigated the consequences of altered AGAP1 levels
on endosomal trafficking and dendritic spine morphology.
AGAP1 is expressed in neurons of the developing brain,
localizing to axons, dendrites, and dendritic spines that receive
excitatory synapses, where colocalizes with endosomal markers.
Overexpression or down-regulation of AGAP1 levels alter
the recycling of endosome cargoes in dendrites, and alters
spine density. In addition, AGAP1 is downstream of the
BLOC-1 subunit dysbindin, the ortholog of the human SZ
susceptibility gene DTNBP1. Indeed, mRNA and protein
levels of AGAP1 are lower in the hippocampus of mice
carrying null mutations in dysbindin (Bloc1s8sdy/sdy) compared
to their wild type (WT) littermates. Together, these data
support the hypothesis that AGAP1 regulates endosomal
trafficking and dendritic spine morphology during early
brain development downstream of a gene implicated in the
pathogenesis of SZ.
MATERIALS AND METHODS
Plasmids
eGFP and yellow fluorescent protein (YFP) vectors were
purchased from Clontech (Mountain View, CA, USA). WT
AGAP-1 vectors were kindly supplied by Dr. Nie (NIH).
siRNA sequences were selected using siRNA Design SciTool
(Integrated DNA Technologies, Coralville, IA, USA), and
Blast analysis comparing human and rat AGAP1. The 4411
sequence 5′CUACCAUUAA UCUGAAAAAC3′ and the 3890
sequence 5′CCUUCCCAAAUUCACUGUC3′ were purchased
from Integrated DNA Technologies (Coralville, IA, USA).
Antibodies
The polyclonal rabbit antibody against the C-terminus of
AGAP1 was previously characterized, and shown to be specific
for AGAP1 (Nie et al., 2002, 2003, 2005). It recognizes
both human and rodent AGAP1, is specific for AGAP1,
and does not cross react with AGAP2 or other proteins
(Nie et al., 2002, 2003; Xia et al., 2003). The polyclonal
rabbit anti-AGAP1 used in primary cultures was a gift from
Dr. Nie; this antibody was compared to the rabbit anti-
AGAP1 purchased from Sigma, and found to be specific
for the C-terminus of AGAP1. The Sigma rabbit anti-
AGAP1 was used in sections of perfusion-fixed brains.
Mouse anti-synaptotagmin (Syt1) andmouse anti-synaptophysin
antibodies were purchased from Chemicon International, Inc.
(Billerica, MA, USA). Goat anti-Neurabin II (A-20), mouse
anti-MAP-2, mouse anti-EEA1, and mouse anti-transferrin
receptor antibodies were purchased from Zymed Laboratories
Inc. (San Francisco, CA, USA). Mouse anti-PSD-95 clone
K28/43 was purchased from Upstate Biotechnology (Lake Placid,
NY, USA). Mouse anti-GAPDH, goat anti-chromogranin B,
mouse anti-GM130, Texas Red, Cascade blue, FITC-conjugated
anti-rabbit and anti-mouse secondary antibodies, and HRP-
conjugated secondary antibodies were purchased from Santa
Cruz (Santa Cruz, CA, USA). Texas-Red-conjugated anti-
mouse and anti-rabbit secondary antibodies were purchased
from Vector Laboratories, Inc. (Burlingame, CA, USA). Mouse
anti-β-tubulin and mouse anti-actin were purchased from the
Developmental Studies Hybridoma Bank University of Iowa
(Iowa City, IA, USA). Mouse anti-Tau was a gift from Dr. Gail
Johnson (University of Alabama at Birmingham). Rabbit anti-
VAMP-2 was purchased from Synaptic Systems (Göttingen,
Germany).
Mice
Bloc1s8sdy/sdy (sandy) mice have the C57/B6 genetic background,
and were previously described (Larimore et al., 2014).
Mouse genotyping was performed by PCR of genomic
DNA as previously described (Larimore et al., 2014). All
animal procedures were approved by the IUCAC at Emory
University. Mecp2 mice STOCK Mecp2tm1.1Jae/Mmucd
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and their controls were a gift from Dr. LP-M (University
of Alabama at Birmingham) as previously described
(Larimore et al., 2013).
Immunoblot Analyses
Brain lysates were separated by SDS–PAGE and transferred to
PVDF membranes (BioRad, Hercules, CA, USA). Membranes
were probed with primary antibodies followed by HRP-
conjugated anti-rabbit and anti-mouse secondary antibodies
(Santa Cruz Biotechnology, Santa Cruz, CA, USA). Secondary
antibodies were detected using Supersignal West Dura Extended
Duration substrate (Pierce Chemical, Rockford, IL, USA) and
film developing.
Synaptosome Preparation
Synaptosomes were prepared from postnatal-day (P) 23 WT
mice, as previously described (Larimore et al., 2011). Briefly,
mice were anesthetized by CO2 inhalation, and their brains
quickly transferred to ice-cold phosphate-buffered saline (PBS).
Tissue was homogenized by 16 strokes of a Potter-Elvehjem
homogenizer at 800 rpm in 0.32M sucrose, 5 mM HEPES,
and 0.5 mM EDTA, supplemented with complete anti-protease
inhibitor (Roche Molecular Biochemicals; Indianapolis, IN,
USA). Homogenates were spun at 1000× g for 10 min and
S1 supernatants were further sedimented at 12,000× g for
20 min. The resulting P2 pellet was resuspended in 8.5% Percoll
(Sigma-Aldrich). The resuspended P2 pellet was then loaded
on a discontinuous gradient comprised of 10 and 16% Percoll
(Larimore et al., 2011). Gradients were spun at 15,000× g for
20 min.
Neuronal Cultures and Electroporation
Transfections
Hippocampal neurons were cultured form embryonic day (E)
18 Sprague-Dawley rat embryos dissected from pregnant rats
(purchased from Charles Rivers Laboratories, Wilmington, MA,
USA), as previously described (Larimore et al., 2009). Dissociated
neurons were plated on poly-L-lysine (Sigma Aldrich, St. Louis,
MO, USA) coated glass cover-slips, and cultured for 3–14 days
in vitro (DIV). Dissociated neurons were transfected while in
suspension using Amaxa nucleofection (Lonza, Walkersville,
MD, USA). Dissociated neurons (2 × 106) were transfected with
3 µg plasmid DNA or 3 µg of each siRNA. Medium was added,
and neurons were plated at a density of 6× 104 cells per well in a
12-well plate.
Immunocytochemistry
Hippocampal neurons on cover-slips were fixed with ice-
cold 3.7% formaldehyde in phosphate buffer (PB; 23 mM
NaH2O4, 80 mM Na2HPO4) for 20 min, permeabilized with
ice-cold 3.7% formaldehyde containing 0.25% Triton X-100
for 10 min, washed three times in PBS, and then blocked
with 10% bovine serum albumin (BSA) for 1 h at 37◦C.
Primary and secondary antibodies were diluted in 3% normal
horse serum (NHS) in PBS. Cover-slips were incubated in
primary antibodies at 4◦C overnight, and then washed three
times for 10 min at room temperature (RT). Cover-slips were
incubated in secondary antibodies for 2 h at RT. Coverslips
were washed three times for 10 min each, once with ddH20,
and finally mounted on glass slides with Vectashield with or
without DAPI (Vector Laboratories, CA, USA). Cover-slips with
immunostained neurons were imaged in an epifluorescence
inverted microscope (Olympus IX 70) with 40× (X NA) and
100× (X NA) oil-immersion objectives using a monochromatic
cooled CCD camera (Retiga 1300, Qimaging, British Columbia,
Canada). Images were deconvolved and merged using the
microtome extension of IP Lab software (Scanalytics, Rockville,
MD, USA), colocalization was measured using the Fluorescence
CV extension of IP Lab.
Transferrin Recycling Assay
Transferrin uptake and trafficking was assayed in neurons
as previously described (Prekeris et al., 1999). Hippocampal
neurons were transfected using Amaxa nucleofection after
dissociation and while in suspension. Neurons were then plated
and cultured for 3 DIV, serum starved in imaging buffer for
1 h, and incubated with 50 µg/ml Alexa-transferrin (Alexa-
Tf; Molecular Probes, Carlsbad, CA, USA) in 1% BSA for
30 min at 37◦C to label the recycling endosome pool. Neurons
were washed and incubated with 100 µg/mL unlabeled holo-
transferrin (Sigma Aldrich, St. Louis, MO, USA) to allow
transferrin to exit the recycling endosome, and then fixed with
4% paraformaldehyde either immediately or after a 45 min
chase. Colocalization was measured using Fluorescence CV
extension IP Lab, and expressed in percentages for statistical
comparisons.
Organotypic Hippocampal Slice Cultures
and Biolistic Transfection
Hippocampal slices were prepared from P7 to P10 Sprague-
Dawley rats, and maintained in vitro as previously described
(Alonso et al., 2004). Slice cultures were transfected by biolistic
gene transfer at 6–8 DIV, as described (Boda et al., 2004;
Chapleau et al., 2008). Plasmid cDNA encoding enhanced yellow
fluorescent protein (eYFP; Clontech, Mountain View, CA, USA)
was precipitated onto 1.6-µm diameter colloidal gold (Bio-
Rad, Hercules, CA, USA) at a ratio 25 µg DNA eYFP and
45 µg AGAP1–10 mg gold, and coated onto Tefzel tubing,
following manufacture’s protocol. For the siRNA, 40 µg of
siRNA oligo duplex with 20 µg of eYFP were coated onto 10
mg of gold. Slices were bombarded using a modified Helios
gene-gun (Bio-Rad, Hercules, CA, USA; He pressure 100 psi),
fixed and mounted on glass slides with Vectashield for confocal
imaging 3 days after transfection, as described (Chapleau et al.,
2008).
Confocal Imaging and Analysis of
Dendritic Spines
Secondary and tertiary branches of apical dendrites of pyramidal
neurons in the CA1 and CA3 region of hippocampal slice
cultures were acquired in a laser-scanning confocal microscope
(Olympus Fluoview-300, Olympus) using an oil-immersion
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100× objective (NA 1.4; Olympus PlanAPo). eYFP was
excited using an argon laser (488 nm), and detected using
standard FITC filters. Only those pyramidal neurons that
displayed eYFP fluorescence throughout the entire dendritic
tree and lacked signs of degeneration (i.e., ‘‘dendritic blebbing’’)
were imaged. Series of optical sections in the z-axis were
acquired at 0.1 µm intervals through each dendritic branch.
Microscope calibrations were performed using 1.07 µm latex
fluorescent microspheres. Calibrations determined that our
effective lateral (x–y axis) pixel resolution was 0.092 microns per
pixel.
Dendritic spines were identified as small protrusions that
extended ≤3 µm from the parent dendrite, and counted off-
line using NIH ImageJ as described (Chapleau et al., 2008);
spines were counted only if they appeared continuous with the
parent dendrite. Numerical density was estimated by quantifying
the number of spines in several dendritic segments per neuron,
and normalized to 10 µm of dendrite length for statistical
comparisons.
Morphological types of spines were defined from ratios of
spine length, spine head width and spine neck width, which were
measured using ImageJ (NIH), as previously described (Tyler and
Pozzo-Miller, 2003; Boda et al., 2004). We manually measured
the length (L) and the apparent diameter of spine heads (dh)
and spine necks (dn). Type-I spines (aka stubby) had L∼dn∼dh;
Type-II spines (aka mushroom) had dh  dn; and Type-III
spines (aka thin) had L dn.
Immunohistochemistry and Confocal
Microscopy of Brain Sections
Perfusion-fixed brain sections including the hippocampus were
processed for fluorescence immunohistochemistry as previously
described (Larimore et al., 2011, 2013). Mice under anesthesia
were perfused through the heart with lactated ringers followed by
4% glutaraldehyde, brains dissected and sectioned in a vibratome
at 60 µm thickness. Freely-floating sections were rinsed with
PBS, and incubated in 1% sodium borohydride for 20 min
at RT, followed by PBS washes. Sections were blocked with
5% NHS, 1% BSA, and 0.3% Triton X-100 for 60 min at RT.
Sections were incubated in primary antibody solutions for 1 h
at RT (PBS with 1% NHS and 1% BSA with 1:10,000 dilution
of mouse anti-synaptophysin, and 1:100 dilution of rabbit anti-
AGAP1). After rinsing in PBS, sections were incubated for
60 min in secondary antibody solutions (PBS with 1% NHS and
1% BSA and 1:500 dilutions); the following Alexa-conjugated
secondary antibodies were used: anti-mouse 555 (for anti-
Synaptophysin) and anti-rabbit 488 (for anti-AGAP1). Following
PBS washes, sections were incubated in cupric sulfate (3.854
W/V Ammonium Acetate, 1.596 W/V Cupric Sulfate in distilled
water, pH 5) for 30 min, washed with PBS, and mounted on
glass slides with Vectashield. Sections were imaged by laser-
scanning confocal microscopy (LSM-510, Axiovert 100M, Zeiss)
using 10X/0.5 NA, 20X/0.5 NA dry objectives (Plan Apochromat,
Zeiss), and 40X/1.3 NA and 63X/1.4 NADiC oil objectives. Alexa
fluorophores were excited with Argon and HeNe1 lasers, and
their emission filtered with BP 505-530 and LP 560. Z-stacks were
acquired and a minimum of four stacks per hippocampus were
analyzed.
Quantitative Real Time PCR (qtPCR)
qtPCR was performed as previously described (Larimore et al.,
2013, 2014). Briefly, the hippocampus of P50 Bloc1s8sdy/sdy
(sandy) mice and age-matched WT littermates was dissected
and immediately flash-frozen in liquid nitrogen. Following
TRIzol (Invitrogen Life Technologies, Grand Island, NY,
USA) extraction using SuperScript III First-Strand Synthesis
(Invitrogen Life Technologies, Grand Island, NY, USA),
isolated mRNA was reverse transcribed into cDNA. PCR
amplifications were performed on a LightCycler480 Real Time
plate reader using LightCycler 480 SYBR Green reagents (Roche,
Indianapolis, IN, USA) at 95◦C for 5 min, followed by 45 cycles
of 95◦C for 5 s, 65◦C for 10 s and 72◦C for 20 s, followed
by a 95◦C for 5 s, 65◦C for 2 min and a 97◦C incubation
to determine melting curves. Primers were designed for
dysbindin forward gatcgcagagaggcgaga and dysbindin reverse
tgagatgtccatcaggtcca; Pallidin forward ctccagacggggtccttac
and pallidin reverse agtccttcatctggagacgtg; Vamp2 forward
tgcacctcctccaaacctta and Vamp2 reverse agctccgacaacttctggtc;
and finally, AGAP1 forward gccgaccagtggagtgac and AGAP1
reverse tacttgggctggaacacacc. PCR amplification was performed
in duplicate with a minimum of three WT samples, and
three mutant samples. Relative amplification was assigned
a concentration value based on standard curves performed
prior to the experiments, and normalized to within-plate
controls.
STATISTICS
Statistical comparisons were made with the engine1.
Kolmogorov-Smirnov tests were performed with the engine2.
Means were compared with two-tailed Student’s t-tests. The
proportions of dendritic spine types were compared by with the
Fisher Exact test. P values <0.05 were considered statistically
significant. Spine density and morphology measurements were
done blinded.
RESULTS
Endogenous AGAP1 Localizes to Dendritic
Endosomes of Hippocampal Neurons
We determined expression of AGAP1 during development,
AGAP1 was detected as early as E10 in whole embryos, and
at E16.5 in brain, increasing during prenatal and postnatal
development. Consistent with published observations (Nie
et al., 2002), two isoforms of AGAP1 (89 and 93 kDa)
were detected in brain using the AGAP1 specific antibody
(Figure 1). Interestingly, the two isoforms demonstrated
differential developmental expression in brain. The 89 kDa
isoform is highly expressed earlier, peaking between P2–P7,
1https://www.cog-genomics.org/software/stats
2http://www.physics.csbsju.edu/stats/KS-test.n.plot_form.html
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FIGURE 1 | Developmental expression and neuronal localization of endogenous Arf1 GTPase activating protein (AGAP1). (A) Immunoblot analysis of
AGAP1 protein levels in lysates from whole mouse embryo (E10 and E12.5) and whole mouse brain (E16.5—adult), using a previously characterized specific anti-C
terminal peptide antibody (Nie et al., 2002). E16.5 was the first time point that the brain was dissected from other body regions. Thirty Microgram of total protein was
loaded in each lane. (B) Transcript abundance measured as log2 RPKM (reads per kilobase per million) in developing human hippocampus for the genes
ADP-ribosylation factors (Arf1; ENSG00000143761) and AGAP1 (ENSG00000157985). Data were downloaded from http://www.brainspan.org/. Note that
expression of Arf1 and AGAP1 transcripts are stable during pre and postnatal development. Post conception week (pcw)
(http://www.ncbi.nlm.nih.gov/pubmed/23193282).
whereas the 93 kDa isoform peaks between P14–P21, and
persists into adulthood (Figure 1). We analyzed the anatomical
distribution of the mouse AGAP1 transcript using the Allen
Brain Atlas. The AGAP1 transcript was expressed in all regions,
including the hippocampus, thalamus, brain stem, cerebellum,
cortex and spinal cord3. The hippocampus is a site where
3http://mouse.brain-map.org/gene/show/110324
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expression was among the highest expression areas of the brain.
Therefore, we focused our experiments in this anatomical region.
We used the Brainspan database and focused on the human
hippocampus to assess the developmental expression of AGAP1
and Arf1 transcripts4. Arf1 and AGAP1 transcript levels were
roughly similar between embryonic and adult hippocampus in
clear contrast with transcripts with protein expression in rodent
brain (Figure 1B).
Next, we analyzed the subcellular distribution of AGAP1
in cultured hippocampal neurons by subcellular fractionations.
We prepared synaptosome-enriched fractions from P21 animals
because the majority of synapses have been formed in
mouse brain at this age. We detected the two isoforms
(89 and 93 kDa) in both the supernatant (S2) and the crude
microsome/synaptosome fractions (P2) (Figure 2A), which were
described in cell lines (Nie et al., 2002). Further fractionation of
the P2 fraction yielded an enriched synaptosome fraction (Syn)
containing both presynaptic and postsynaptic compartments,
confirmed by the detection of the synaptic vesicle marker Syt, and
the postsynaptic density protein PSD95, respectively (Gordon-
Weeks, 1987). AGAP1 was enriched in the Syn fraction over
the P2 fraction at a level comparable to those of Syt1 and
PSD95 (Figure 2A). Our findings are in line with previous data
demonstrating first that the Arf that AGAP1 regulates, Arf1, is
also localized to the synaptic region (Park et al., 2004, 2006;
Kennedy and Ehlers, 2006). Second, our results expand previous
biochemical evidence identifying AGAP1 in the PSD fractions
(Yoshimura et al., 2004).
The localization of AGAP1 in axons and dendrites of cultured
hippocampal neurons was determined by immunocytochemistry
imaged by confocal fluorescence microscopy. We determined
the upper and lower limits of protein colocalization by
immunolabeling two proteins in the same compartment
(secretogranin-3 and chromogranin-B), and two proteins
in separate compartments (chromagranin-A and LAMP1),
which yielded ∼65% and ∼7% colocalization, respectively.
AGAP1 colocalized preferentially with two markers of
dendritic compartment: MAP2 (52%) and the dendritic
spine marker neurabin/spinophilin (35%), and slightly less
with the postsynaptic marker PSD95 (17%; Figures 2B,C). In
contrast, AGAP1 colocalized only slightly above nonspecific
levels with the axonal marker Tau (17%) and the presynaptic
markers SV2 (15%) and Syt1 (18%; Figures 2B,C). In summary,
AGAP1 preferentially colocalizes with postsynaptic dendrites
and dendritic spines.
We then determined if AGAP1 localizes to endosomal
compartments in dendrites in E18 hippocampal neurons.
We compared AGAP1 localization with markers of vesicular
compartments in dendrites (Figure 3). AGAP1 colocalized with
transferrin receptors (40%), which label recycling endosomes,
and with EEA1 (33%), which labels early endosomes (Figure 3;
Parton et al., 1992; Prekeris et al., 1999; Park et al., 2004).
AP-3 is a binding partner of AGAP1 that is expressed in
both axons and dendrites, localizing to endosomes (Austin
et al., 2002; Robinson, 2004; Salazar et al., 2004; Newell-Litwa
4http://www.ncbi.nlm.nih.gov/pubmed/23193282
et al., 2007). Indeed, AGAP1 colocalized strongly with AP-3
in hippocampal neurons (49%; Figure 3). Significantly lower
colocalization was observed between AGAP1 and chromogranin
B (15%), a marker of the regulated secretory pathway expressed
in both axons and dendrites (Figure 3). Thus, consistent with
data from non-neuronal cells, endogenous AGAP1 localizes
predominantly to an AP-3 positive endosomal compartment in
primary hippocampal neurons.
Null Mutations of BLOC-1 Reduce The
Expression Levels of AGAP1
AGAP1 associates with AP-3 and the BLOC-1 subunit dysbindin
(Nie et al., 2003; Bendor et al., 2010). The BLOC-1 complex
is an octameric complex containing dysbindin, pallidin, muted,
cappucino, snapin, and BLOS1–3. In non-neuronal cells,
BLOC-1 regulates trafficking from endosome lysosome-related
organelles (Salazar et al., 2006, 2009; Li et al., 2007; Newell-Litwa
et al., 2009; Ghiani andDell’Angelica, 2011;Marks et al., 2013). In
neuronal cells, BLOC-1 regulates vesicle trafficking from somatic
endosomes to the synapse, as well as vesicle recycling at the
synapse (Newell-Litwa et al., 2010; Larimore et al., 2011).
Since the AP-3 and BLOC-1 subunits AP3B2 and DTNBP1
are risk factors for ASD and SZ, respectively, we tested
whether AGAP1 and BLOC-1 participate on a common signaling
pathway by analyzing whether AGAP1 expression was sensitive
to BLOC-1 deficiency. To this end, we first determined
AGAP1 mRNA levels in the hippocampus of adult (P50) male
Bloc1s8sdy/sdy (sandy) mice, which lack dysbindin, by qtPCR.
Indeed, AGAP1 mRNA levels are significantly lower in the
hippocampus of Bloc1s8sdy/sdy (sandy) mice than in that of age-
matched WT mice (p = 0.04; Figure 4A). Next, we estimated
AGAP1 protein levels by immunohistochemistry and confocal
microscopy in the hippocampus of Bloc1s8sdy/sdy mice, as a
ratio of synaptophysin levels, which are not altered in BLOC-1
mutants (Newell-Litwa et al., 2010; Larimore et al., 2011;
Gokhale et al., 2012). Consistent with mRNA levels, AGAP1
fluorescence intensity was significantly lower in the dentate gyrus
of Bloc1s8sdy/sdy mice (p= 0.0001; Figures 4B,C). Together, these
data demonstrate that loss of dysbindin, a subunit of the SZ
susceptibility factor BLOC-1, results in lower mRNA and protein
levels of AGAP1.
Because AGAP1 is an Arf1 GAP, we wanted to determine the
levels of Arf1 in the hippocampus of Bloc1s8sdy/sdy (sandy) mice.
We prepared isolated synaptosomes from the hippocampus of
WT and Bloc1s8sdy/sdy (sandy) mice. Synaptosomes were probed
for Arf1, Hsp90 (control) and SV2 (synaptic vesicle protein 2)
as a marker of synaptic vesicles. No significant difference was
observed in the protein levels of Arf1 between WT and the
Bloc1s8sdy/sdy (sandy) synaptosomes (Figure 4D).
Null Mutations of Mecp2 Reduce mRNA
but not Protein Levels of AGAP1
We previously demonstrated that transcript and protein
expression of the BLOC-1 complex subunit pallidin require
Mecp2 (Larimore et al., 2013). Mutations in MECP2 result
in Rett Syndrome, a neurodevelopmental disorder that is
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FIGURE 2 | Synaptic Localization of AGAP1. (A) Immunoblot analysis of AGAP1 and synaptic markers in fractionated P23 whole rat brain. H-whole brain
homogenate, P2-crude microsomes/synaptosomes, S2-supernatant, and Syn-pure synaptosome fraction. Ten micrograms of protein was loaded for each fraction.
(B) Regions of interest (ROIs) from endogenous immunocytochemistry micrographs imaged from 14 Days in vitro (DIV) dissociated rat E18 hippocampal neurons.
White arrows indicate regions of colocalization. Green: endogenous AGAP1. Red: MAP-2, neurabin, PSD95, Tau, synaptotagmin (Syt), and SV2 as indicated. Scale
bar = 10 µm. (C) Quantification of colocalization within ROIs of endogenous AGAP1 and subcellular markers. Data were quantified from three independent
experiments (n = 10).
classified as an ASD. Based on this, we tested Mecp2+/y and
Mecp2−/y to determine AGAP1 expression. First we determine
AGAP1 mRNA levels in the hippocampus of adult (P50) mice.
Results from qtPCR demonstrate reduced levels of AGAP1
mRNA in Mecp2−/y mice compared to controls (p = 0.003;
Figure 5A). However, this reduction on AGAP1 mRNA levels
did not translate into decreased AGAP1 protein expression as
determined by immunohistochemistry and confocal microscopy
in the hippocampus of Mecp2−/y mice. AGAP1 fluorescence
intensity was unaltered in the dentate gyrus of Mecp2−/y mice
(p = 0.6; Figures 5B,C). These data suggest that AGAP1 mRNA
phenotypes are compensated at the protein expression level in
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FIGURE 3 | Endogenous AGAP1 localizes to neuronal endosomal compartments. (A) Immunocytochemical analysis of endogenous AGAP1 compared with
vesicular compartment markers in 14 DIV dissociated rat E18 hippocampal neurons. White arrows indicate regions of colocalization. Green: AGAP1 and red:
chromogranin B, adaptor protein 3 (AP-3), transferrin receptor, and early endosome antigen 1 (EEA-1) as indicated. Scale bar = 10 µm. (B) Quantification of
colocalization within ROIs of endogenous AGAP1 with vesicular compartment markers. Background colocalization (∼7%) is not subtracted. Data were quantified
from three independent experiments (n = 10).
Mecp2−/y mice. Our data argue that AGAP1 phenotypes are not
a general feature downstream of genetic defects associated to
neurodevelopmental disorders.
AGAP1 Affects Transferrin Trafficking in
Dendrites of Hippocampal Neurons
Overexpression of AGAP1 in non-neuronal cells results in
the accumulation of transferrin in large punctate structures
(Nie et al., 2002, 2005). In hippocampal neurons, transferrin
is endocytosed into dendrites via transferrin receptors, and
traffics through the recycling endosomal compartment that
contains Rab11 (Parton et al., 1992; Prekeris et al., 1999; Park
et al., 2004, 2006). Based on the significant colocalization of
AGAP1 with transferrin receptors, we tested whether up or
down regulation of AGAP1 affects transferrin trafficking in
dendrites of hippocampal neurons by imaging the trafficking of
Alexa-transferrin (Alexa-Tf). After 30 min of bath application
of Alexa-Tf, we chased cells with unlabeled transferrin to
determine if Alexa-Tf exits recycling endosomes properly.
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FIGURE 4 | AGAP1 is altered in the hippocampus of Biogenesis of Lysosome Related Organelles Complex-1 (BLOC-1) deficient mice. (A) Relative
mRNA levels in the hippocampus for wild type (WT; gray) and Bloc1s8sdy/sdy (green). Negative control Vamp2 (V2) and positive controls Dysbindin. No significant
difference was measured for mRNA levels of V2. In Bloc1s8sdy/sdy , there was a significant decrease of dysbindin (p = 0.005). AGAP1 mRNA levels were significantly
decreased in Bloc1s8sdy/sdy (p = 0.01). (B) Micrographs of the dentate gyrus at 20× for WT and Bloc1s8sdy/sdy . In red is synaptophysin and in green is AGAP1.
(C) Quantification of the intensity levels of AGAP1 compared to synaptophysin in BLOC-1 deficient mice. AGAP1 intensity levels were significantly decreased in
Bloc1s8sdy/sdy (p = 0.0001). (D) Arf1 levels in synaptosomes prepared in WT and Bloc1s8sdy/sdy mice. Hsp90 is a loading control, and SV2 is a synaptic vesicle
marker to show enrichment of synaptosomes. No differences between WT and Bloc1s8sdy/sdy hippocampus for Arf1 levels as compared with loading controls actin
(not shown) and Hsp90. N = 6 animals analyzed in three fractionations.
After 30 min at 37◦C, Alexa-Tf showed a punctate pattern
colocalizing extensively with the recycling endosome marker
Rab11 (Figure 6). Immediately after the chase with unlabeled
transferrin, 57% of Rab11 positive endosome puncta were
also positive for Alexa-Tf (Figure 5), demonstrating Alexa-Tf
persistence in the recycling endosome. After 45min of chase with
Frontiers in Cellular Neuroscience | www.frontiersin.org 9 September 2016 | Volume 10 | Article 218
Arnold et al. AGAP1 Regulates Spine Morphology
FIGURE 5 | Null mutations of Mecp2 reduce mRNA but not protein levels of AGAP1. (A) Relative mRNA levels in the hippocampus for WT (gray) and
Mecp2−/y (green). Negative control Vamp2 (V2) and positive controls Mecp2. No significant difference was measured for mRNA levels of V2. In Mecp2−/y , there was
a significant decrease of Mecp2 (p = 0.005). AGAP1 mRNA levels were significantly decreased in Mecp2−/y (p = 0.003). (B) Micrographs of the dentate gyrus at
20× for WT and Mecp2−/y . In red is synaptophysin and in green is AGAP1. (C) Quantification of the intensity levels of AGAP1 compared to synaptophysin in
Mecp2−/y mice. AGAP1 intensity levels were not significantly decreased in Mecp2−/y (p = 0.6).
unlabeled transferrin, there was a significant reduction in the
intensity of Alexa-Tf, suggesting that transferrin had trafficked
out of recycling endosomes to either the plasma membrane or
cell body (Figure 6).
In control neurons and neurons overexpressing AGAP1, there
were no significant differences in the colocalization of Alexa-
Tf with Rab11-labeled recycling endosomes immediately after
the chase with unlabeled transferrin (Figure 6). In contrast,
overexpressing AGAP1 increased the levels of Alexa-Tf that
remained in the Rab11-positive compartment after 45 min of
chase (Figure 6), suggesting a slower rate of Alexa-Tf trafficking
out of recycling endosomes. When AGAP1 was knockdown
with siRNA, the uptake of Alexa-Tf was unaffected immediately
after the chase (Figure 6). However, the levels Alexa-Tf that
remained in the Rab11-positive compartment after 45 min
of chase were lower in AGAP1 siRNA-expressing neurons
compared to control cells (Figure 6), suggesting that down
regulation of AGAP1 increases the rate of transferrin recycling
in dendrites. These gain and loss-of-function data support a role
for AGAP1 in endosomal trafficking in dendrites of hippocampal
neurons.
AGAP1 Modulates the Morphology of
Dendritic Spines
Disruption of endosomes or altering dysbindin levels affects the
morphogenesis of dendritic spines (Park et al., 2006; Jia et al.,
2014). Therefore, we tested whether AGAP1 overexpression
or siRNA-mediated knockdown affected dendritic spines of
CA1 and CA3 pyramidal neurons in organotypic cultures
of hippocampal slices, which preserve neuronal integrity and
hippocampal circuitry, developing in vitro similarly as in vivo
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FIGURE 6 | Manipulation of AGAP1 in neuronal dendrites alters transferrin trafficking. (A) Micrographs of 3 DIV E18 rat hippocampal neurons co-expressing
eGFP and control plasmid, scrambled oligos, knock-down with siRNA, and overexpression of WT AGAP-1. Red: Alexa-transferrin (Alexa-Tf); Green: Rab11. White
box outlines a ROI enlarged beneath the micrograph. Right panels: transferrin uptake was determined after 30 min (0 min). Left panels: recycling was assessed after
45 min following incubation with unlabeled transferrin (45 min). Scale bar = 10 µm. (B) Quantification of percent colocalization within ROIs of Rab11 puncta with
Alexa-Tf. Data were quantified from three independent experiments (n = 10). At the 0 min time point no significant difference was observed between the
colocalization of Rab11 and Alexa-Tf in scrambled vs. siRNA for AGAP1 (p = 0.6) and control plasmid vs. overexpressed AGAP1 (p = 0.9). At the 45 min time point,
colocalization of Rab11 and Alexa-Tf was significantly different in scrambled vs. siRNA for AGAP1 (p = 0.0002) and for control plasmid vs. overexpressed AGAP1
(p = 0.0002).
(Lo et al., 1994; Gähwiler et al., 1997; Alonso et al., 2004).
Neurons in slice cultures were cotransfected with eYFP and either
WT AGAP1 or siRNA for AGAP1. CA1 and CA3 pyramidal
cells were identified by their characteristic morphology and
anatomical location within an hippocampal slice. Previous
studies have shown that over 90% of neurons in slice cultures
transfected with two cDNA plasmids by biolistic gene transfer
express both proteins (Moore et al., 2007; Chapleau et al.,
2009).
Pyramidal neurons that overexpressed WT AGAP1 had
significantly lower dendritic spine density, with an average
40% reduction (4.7 spines/10 µm in AGAP1 vs. 8.0 spines/10
µm in control; Figure 7, p = 0.02). On the other hand,
siRNA-mediated AGAP1 knockdown caused a change in spine
density that did not reach statistical significance (10.6 spines/10
µm in siRNA vs. 8.0 spines/10 µm in control; Figure 7,
p= 0.08).
We blindly quantified spine morphological changes after
genetic manipulation of AGAP1 activity. We either expressed
data as absolute values in spine length; neck, and head size
(Figure 7C) or we categorize spines as spiny, stubby or
mushroom shaped spines according to Boda and Pozzo-Miller
(Tyler and Pozzo-Miller, 2003; Boda et al., 2004; Figure 7D).
Spine length and neck size were significantly increased by
either up or down regulation of AGAP1 (Figure 7C). Next,
we compared the proportions of spine classes according to
a classification scheme of three morphological types: stubby,
mushroom and thin (Tyler and Pozzo-Miller, 2003; Boda
et al., 2004). Both siRNA-mediated AGAP1 knockdown and
AGAP1 overexpression altered the proportions of spine types
from predominately mushroom spines to primarily immature
spines (Figure 7D). The proportion of thin spines increased
to ∼60% after AGAP knockdown (p = 5.55 × 10−13,
Fisher’s exact test), and to ∼67% after AGAP1 overexpression
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FIGURE 7 | Manipulation of AGAP1 levels alters spine density and morphology in CA1/CA3 neurons in organotypic hippocampal slice cultures.
(A) Representative dendritic segments of CA1/CA3 pyramidal neurons from organotypic slice cultures transfected with yellow fluorescent protein (YFP) and control
plasmid, scrambled oligos, siRNA or overexpression of WT AGAP1. Scale bar = 2 µm. (B) Quantification of spine density in each condition. Data were quantified
from three independent experiments (n = 8–12 dendrites). Significant decrease in spine density was observed in AGAP1 overexpressing slice cultures (p = 0.02). No
significant change was observed in spine density in siRNA treated slice cultures (p = 0.5). (C) Quantification of spine length, neck size, and spine head diameter in
each condition. Data were quantified from three independent experiments (n = 8–12 dendrites). There was significant increase in spine length (p < 0.0001) by either
up or down regulation of AGAP1. There was significant increase in the diameter of spine neck (p < 0.0001) by either up or down regulation of AGAP1. No significant
change in spine head diameter was observed. (D) Quantification of spine morphology in each condition. Data were quantified from three independent experiments,
three separate cells per condition, 8–12 pieces of dendrite per cell. N = the number of spines counted. Thin spines increased to ∼60% after siRNA AGAP
down-regulation (p < 10−12 Fisher’s exact test) or to ∼67% after overexpression of AGAP1 (p < 10−29 Fisher’s exact test).
(p = 5.30 × 10−13; Figure 7). These data demonstrate that
AGAP1 levels modulate both dendritic spine density and
the proportion of morphological spine types in hippocampal
pyramidal neurons.
DISCUSSION
Genes encoding dysbindin and AGAP1 have been implicated
as risk factors for SZ and ASD. Moreover, here we demonstrate
that deficiencies in AGAP1 generate dendritic spine deficits
characteristic of developmental disorders associated with
intellectual disabilities (Penzes et al., 2011, 2013; Seshadri
et al., 2013). We describe the subcellular localization and
consequences on neuronal morphology of altering the
levels of AGAP1, the first Arf1-GAP to be characterized
in developing neurons. AGAP1 is expressed in the cortex,
thalamus, hippocampus, and brainstem. The results presented
in this study indicate that AGAP1 is a regulator of endosomal
trafficking in neurons, and a negative regulator of dendritic
spine formation and maturation. We also demonstrate that loss
of the BLOC-1 subunit dysbindin alters AGAP1 mRNA levels
and immunoreactivity in the dentate gyrus. We postulate that
BLOC-1 resides upstream of AGAP-1 to regulate endocytic
recycling in dendritic spine endosomes. This BLOC-1-AGAP1
pathway is insensitive to genetic defects in Mecp2, indicating
that neurodevelopmental disorder genes such as Mecp2
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and DTNBP1 use different mechanisms to control spine
morphology.
AGAP1 localizes to axons, dendrites, dendritic spines
and synapses in developing hippocampal neurons, and
during prenatal and early postnatal brain development.
This period in development corresponds to a phase of
differentiation of axons and dendrites, especially their
growth and arborization, formation of dendritic spines and
synapses in the cortex and hippocampus (Gaarskjaer, 1981;
Melloni and De Gennaor, 1994), suggesting that AGAP1
participates in these developmental events. In agreement
with this model, siRNA-mediated AGAP1 knockdown
resulted in higher dendritic spine density, and a higher
proportion of immature thin dendritic spines (Type-3),
while AGAP1 overexpression caused exactly the opposite
results (lower density of spines, more thin spines). Previous
studies reported that loss-of-function of dysbindin decreased
spine density, a phenotype reminiscent of the AGAP1
gain-of-function phenotype (Jia et al., 2014); this result
was unexpected because dysbindin loss leads to lower
levels of AGAP1. However, there are some differences
in experimental preparations: Jia et al. (2014) utilized
hippocampal neurons isolated from E18 to E19 Bloc1s8sdy/sdy
(sandy) mice, which lacked dysbindin throughout their
development. Here, we acutely downregulated AGAP1
levels in organotypic cultures of hippocampal slice from
P7 to 10 rats, where neurons had developed normally until
the time of AGAP1 siRNA expression. These differences in
the developmental time of AGAP1 deletion may account for
the apparent discrepancy in the numerical density of dendritic
spines. Regardless, both AGAP1 and BLOC-1 regulate an
endosomal pathway that participates in the formation and
morphological maturation of dendritic spines during brain
development.
Endogenous AGAP1 colocalizes extensively with markers
of early and recycling endosomes in dendrites (Nie et al.,
2002, 2005). Here, we studied how AGAP1 expression levels
affect endosomal trafficking in dendrites. Down regulation
of AGAP1 enhanced the rate of transferrin trafficking in
dendrites, while AGAP1 overexpression caused the exact
opposite result. Endosomal trafficking in dendrites is necessary
for several functions, including activity-dependent synaptic
plasticity (e.g., long-term potentiation, LTP) and regulation
of dendritic spine morphology. Previous studies demonstrated
that a collapse of recycling endosomes reduces spine density
in an activity-dependent manner (Park et al., 2006). In
addition, recycling endosomes located at the base of dendritic
spines regulate spine growth during LTP (Blanpied and
Ehlers, 2004; Park et al., 2004, 2006; Blanpied et al., 2008).
Based on these combined observations, the possibility that
AGAP1 participates in neuronal differentiation by regulating
endosomal trafficking is intriguing. Here, we propose a
mechanism whereby dysbindin regulates AGAP1 expression
to modulate spine density and morphology. Collectively,
these data indicate that fine-tuned expression of AGAP1
is necessary the formation and maturation of dendritic
spines during brain development, suggesting that AGAP-
dependent mechanisms play a role in the pathogenesis of
neurodevelopmental disorders.
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